Amerant Bancorp Completes $50M Senior Notes Offering

Amerant Bancorp (NYSE: AMTB) has finalized a $50 million offering of senior unsecured, unsubordinated notes maturing on September 17, 2031. The instrument carries a fixed coupon of 7.00%, with interest payments scheduled semi-annually beginning March 17, 2027. This transaction increases the bank's long-term debt load but provides immediate liquidity to support operational needs.

According to GN stocks/banks reporting, the proceeds are designated for general corporate purposes, including working capital, supporting organic loan growth, repaying existing obligations, and potentially executing Class A share repurchases. By securing this funding now, management aims to mitigate reliance on volatile short-term deposits and create a stable base for balance sheet expansion.

Senior Notes Add Fixed Cost Liability

The new notes rank pari passu with other senior obligations and ahead of subordinated debt. For Amerant Bancorp, this increases the proportion of fixed-rate liabilities in the funding mix. While this reduces refinancing risk associated with shorter-term debt, it introduces a consistent 7.00% interest expense that will impact net interest margin. The company must deploy this capital efficiently to ensure the return on assets exceeds the cost of this new funding.

Investors should note that the issuance does not alter the bank’s core credit risk profile. The primary strategic goal is to provide flexibility in a market where deposit competition remains intense. By locking in this rate, Amerant Bancorp secures a predictable funding stream, allowing it to focus on loan production and cost control without immediate pressure to raise short-term capital.

Forecasts Assume Continued Margin Expansion

Market consensus projects Amerant Bancorp to reach revenues of $481.3 million and earnings of $181.3 million by 2029. This trajectory assumes annual revenue growth of 7.1%, driven by higher-yielding loan production and improved cost efficiency. The current earnings base stands at $56.4 million, meaning the bank must nearly triple its profitability to meet these targets. The new notes offering is a tactical step to enable this growth, but execution remains the critical variable.

The path to these figures relies on maintaining net interest margins while absorbing the new interest expense. If loan growth stalls or credit quality deteriorates, the fixed cost of the 7.00% notes could pressure profitability. Conversely, if the bank successfully deploys the funds into higher-yielding assets, the additional capital can support earnings per share through potential buybacks and organic expansion.

Credit Risk Remains Key Watchpoint

Despite the added financial flexibility, Amerant Bancorp continues to face challenges with rising nonperforming loans and low bad loan coverage. These credit metrics remain central to the investment thesis. The new funding does not resolve existing credit weaknesses; it merely provides the liquidity to manage them. Management must balance the desire for growth with the need to maintain adequate provision levels, as any increase in credit losses would directly erode the benefits of the new capital.

The timing of this issuance also coincides with ongoing strategic reviews, including the potential sale of the Houston franchise. How management allocates the $50 million between loan growth, debt reduction, or equity repurchases will signal their confidence in the bank’s credit outlook. For shareholders, the key takeaway is that the bank has secured a long-term funding source, but the fundamental value creation depends entirely on the quality of the assets purchased with that money.